Buscar | Friends - Best Social Network - החברים

Sindhuri Kotamraju agregó una foto Health
2025-07-17 12:28:06

How MASH is Shaping the Future of Liver Disease
Metabolic Dysfunction-Associated Steatohepatitis (MASH), formerly known as Non-Alcoholic Steatohepatitis (NASH), is quickly emerging as a major global health concern. Closely linked to metabolic conditions such as obesity, type 2 diabetes, and insulin resistance, MASH represents a progressive form of fatty liver disease that can lead to serious complications like liver cirrhosis, failure, or...

0 Commentarios 0 Acciones 562 Views 0 Vista previa

Please log in to like, share and comment!
Devidi Jahnavi agregó una foto Health
2025-06-17 05:49:14

Latest Treatment Approaches in Advanced Liver Cancer
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and represents a significant global health burden. Accounting for nearly 90% of all primary liver malignancies, HCC typically arises in the setting of chronic liver disease and cirrhosis. The global incidence is increasing, particularly in regions with high rates of hepatitis B and C, alcoholic liver disease, and...

0 Commentarios 0 Acciones 840 Views 0 Vista previa

Please log in to like, share and comment!
Devidi Jahnavi agregó una foto Health
2025-07-03 06:37:34

Liver Cancer Treatment Market Outlook: Key Players and Regional Insights
What is the projected growth rate (CAGR) of the Liver Cancer Treatment Market from 2025 to 2033, and what is the market value expected to change by 2033? The Global Liver Cancer Treatment Market size reached US$4.58 billion in 2024 and is expected to reach US$12.88 billion by 2033, growing at a CAGR of 11.4% during the forecast period 2025-2033. What is Liver Cancer Treatment Market? Liver...

0 Commentarios 0 Acciones 665 Views 0 Vista previa

Please log in to like, share and comment!
Kranthi Reddy agregó una foto Health
2025-06-19 11:47:47

Precision Medicine and Immunotherapy Redraw Liver Cancer Treatment Landscape
Liver Cancer Therapeutics Market Set to Surge Beyond $15.7 Billion by 2032 on Innovation and Global Demand The Liver Cancer Therapeutics Market is entering a pivotal period of rapid growth. Projected to rise from approximately USD 3.1 billion in 2023 to USD 15.7 billion by 2032, the sector is experiencing a compound annual growth rate (CAGR) of nearly 7.9%. Some forecasts predict even faster...

0 Commentarios 0 Acciones 1K Views 0 Vista previa

Please log in to like, share and comment!
Uttej Netha agregó una foto Health
2025-06-30 10:41:33

U.S. Dominates Global MASH Therapy Landscape with 43% Market Share
The North America Metabolic Dysfunction–Associated Steatohepatitis (MASH) Treatment Market is witnessing exponential growth, rising from USD 3.70 billion in 2024 to an anticipated USD 17.15 billion by 2033, at a strong compound annual growth rate (CAGR) of 19.3% from 2025 to 2033. This dynamic expansion is fueled by the increasing prevalence of obesity, Type 2 diabetes, aging population,...

0 Commentarios 0 Acciones 938 Views 0 Vista previa

Please log in to like, share and comment!